Results

Total Results: 1,269 records

Showing results for "author year description".

281. Assessing the Impact of Indexing Performance Measure Codes on the Perceived Value of EPC Reports to Health Systems (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-assessing-impact.pdf
     September 01, 2018 - This report is made available to the public under the terms of a licensing agreement between the author … .........................................................................1 Process Description .... … Hospital was ranked #1 in North Carolina, and #1 in the Raleigh-Durham region for the 17th consecutive year … Process Description To create a mock quality measure index we utilized a draft AHRQ report conducted … Process Description Evaluation Methods Results Final Product Description Evaluation Results

282. Methods White Paper: Improving the Utility of Evidence Synthesis for Decision Makers in the Face of Insufficient Evidence (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
     April 01, 2021 - Strategies for addressing insufficient evidence in evidence synthesis programs* Strategy Description … Example Example Description Reconsider eligible study designs In designing the original protocol … Example Example Description Summarize evidence on contextual factors (factors other than benefits … Example Example Description Incorporate health system data into a review Local health system data … Heart. 2010 Aug;96(16):1333; author reply doi: https://dx.doi.org/10.1136/hrt.2010.200758.

283. Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-usability-testing.pdf
     November 01, 2018 - This report is made available to the public under the terms of a licensing agreement between the author … Process Description Development of the summaries involved a three-step process. … Added description of what response rates meant. … Services’ Strategic Clinical Networks Letter of invitation Dear {participant}, Over the next year … One participant pointed out that the year of publication for the included studies should be added.

284. Untitled (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/suicide-prevention_research-protocol.pdf
     December 23, 2015 - Table 1: PICOTS description of inclusion criteria for all key questions Population(s) Received intervention … ‡ See Table 1 for the full PICOTS description Note that the following section does not include … Simple Search, Intervention search term: “Suicide prevention” (16) Intervention Title Description … the following school year; and, • not enrolled in grades 9–12 in by October 1 of the following year … stopped • Planned o Year planned § Data collection’s [anticipated] starting date/year o Validity

285. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/head-neck-cancer_disposition-comments.pdf
     May 27, 2010 - Online: May 27, 2010 2 Comment Section Comment Response Introduction This section provided a description … Abstract No: LBA6006 Citation: J Clin Oncol 27:18s, 2009 (suppl; abstr LBA6006) Author … This would be particularly unfortunate as these under- 65 year old patients are those who stand to benefit … Both RTOG 0022 and 0225 have demonstrated preliminary survival (89-91% 2-year locoregional disease

286. Supplemental Project To Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research.pdf
     June 01, 2017 - The findings and conclusions in this document are those of the author(s), who are responsible for its … Overall description of studies found ................................................................ … Overall description of studies found Study Identifier Papers Author, year, PMID Registry Prospective … , year, PMID Registry Prospective/ retrospective Dates Target N Key Question NCT00579189 CT.gov … Arm details Study Arm description NCT00365092 TT inserted promptly TT inserted up to 9 months later

287. CER 217 Disposition of Comments: Management of Infertility (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-217-management-of-infertility-comments.pdf
     May 14, 2019 - acknowledge the limitations of that approach when they cite how many people will conceive after one year … We have clarified the description. … I think most will not know what this paper is referring to without more of a description. … We have clarified the description of the specific intervention from the included study 101. … We have expanded the description of the national registry of ART procedures to clarify these points

288. Data Points 14: Use of Endocrine Therapy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
     August 01, 2012 - See Table 1 for a crosswalk between year of diagnosis and period of observation. … Age: We grouped women into five-year age groups by age at diagnosis. … Table 1: Description of the cohorts and the number of older women with ductal carci- noma in situ and … Thus we see some year-to-year differences where use rises slightly in a later year than in an earlier … year.

289. Disposition of Comments for Use of Natriuretic Peptide Measurement in the Management of Heart Failure (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
     November 20, 2013 - This needs to be made clearer in the description of the studies throughout the report. … We used the definition of HF as described by each author for his/her study. … diagnostic performance of the natriuretic peptides against the reference criteria provided by each author … Race was checked and information added to the study description section of KQ1, KQ2, KQ6 and KQ7. … We reported only those values that were reported by the author and did not calculate LR+ or LR – if

290. Disposition of Comments Report for Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients Wtih Kidney Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
     August 11, 2014 - troponin assays (e.g., did study findings differ between those published early vs. late during the 23 year … We ran our meta-analysis figures in order by year to see if there was any evidence for a temporal difference … However, this is a highly valuable document that provides both detailed description and summaries of

291. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol.pdf
     January 31, 2023 - considered normal for their age (e.g., a study on how to manage a toddler’s temper tantrum or an 8-year-old … Criteria for grading the risk of bias of individual studies Rating Description and Criteria Low • Least … Description of the strength of evidence grades Strength of Evidence Description High We are very … are stable, i.e., another study would not change the conclusions. 12 Strength of Evidence Description

292. Disposition of Comments for Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-193-disposition-comments-naloxone.pdf
     November 27, 2017 - There is a need to account for the fact that the drugs available on the street tend to vary from year … to year and have recently focused on high potency, inexpensive synthetic opioids and thus data from … Healthcare Research and Quality (AHRQ), Rockville, MD, with the finding and views being that of the author … & Affiliation Section Comment Response Public Reviewer #1, Joi Kelly General Comments The author … This includes description of the same results in various discussion sections provided.

293. Disposition of Comments Report for Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
     October 01, 2014 - We have deleted “physical and chemical” in the bone scan description and now state that “bone scans … Findings (continued) Page 15 line 14-15: description of PET is simplistic. … We agree that a description of an ideal treatment evaluation tool is helpful to this brief and have … More context information may be helpful with basic description of a treatment cycle, duration, timing … Peer Reviewer #5 General Comments Good description of current studies on multiple tests.

294. Topic Brief: Radiation Therapy for Bone Metastases (pdf file)
     effectivehealthcare-admin.ahrq.gov/system/files/docs/topic-brief-radiation-therapy-bone-metastases.pdf
     August 01, 2022 - In the United States, around 350,000 people die each year as the result of bone metastases. … See Appendix B for detailed description of the criteria. … In the US, around 350,000 people die each year from bone metastases. … In the US, around 350,000 people die each year from bone metastases. … References Author Impact of a New Evidence Review Yes.

295. Potential Harms Resulting from Patient-Clinician Real-Time Clinical Encounters using Video-based Telehealth: A Rapid Evidence Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/patient-safety-practices-rapid-protocol.pdf
     September 09, 2022 - Comparator • Usual care without PSP • Care involving a different PSP No clear description of intervention … Data extraction categories will include author, year, study design, characteristics of the patient

296. Comparative Effectiveness of Dietary Supplement Versus No Dietary Supplement Use in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/dietary-supplements/research-protocol
     December 01, 2019 - Report Characteristics KQs 1–5 No limits on publication year or status Publication language … No limits will be placed on publication year or publication status. … reported: Study and report characteristics: study design, study setting, duration of followup, first author … ,year and language of publication, funding source. … d Description of the source, methods of extraction, and constituents of the dietary supplement (e.g.

297. Behavioral Programs for Diabetes Mellitus | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetes-behavior-programs/research-protocol
     December 01, 2019 - vs. >1 year); and, level of glycemic control (i.e., HbA 1c <7 vs. ≥7 percent)? … ) versus longer (>1 year) times since diagnosis. … Author contact will be by email (to the corresponding author of each study), with a primary contact attempt … To guide these discussions, TEP members will be given a list and description of components, delivery … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

298. Disposition of Comments for Quality Improvement Interventions To Address Health Disparities (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
     August 27, 2012 - description. … I found the description clearer in the actual results section. … We have organized by alphabetically by condition and then by author last name. … We have organized by alphabetically by condition and then by author last name. … We have organized by alphabetically by condition and then by author last name.

299. Topic-Brief2-Opioid-Withdrawal (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
     April 01, 2021 - to the systematic reviews found that among patients prescribed long-term opioid therapy in the last year … Studies of treatments to support opioid tapering in patients with chronic pain Strategy Description … Patient-centered prescription opioid tapering in community outpatients with chronic pain: 2- to 3-year … This report is made available to the public under the terms of a licensing agreement between the author … See Appendix B for detailed description of the criteria.

300. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cognitive-decline-disposition-170707pdf.pdf
     March 24, 2017 - It includes a reasonable background literature description, it provides definitions for relevant terminology … Did you follow this approach and if yes, revise this description to improve clarity. … We have revised some elements of the description of the ACTIVE trial. … We have revised our description of the booster assignment but it does not alter the bias conclusion … They do a good job with their description of how bias was rated.